{"title":"Quercetin activates lysosomal function to ameliorate neuroinflammation and cognitive deficits in chronic cerebral hypoperfusion","authors":"Yao Chen, Yibin Jiang, Tang Song, Yongxin Chen, Jing Li, Ning Zhi, Hongqiao Wei, Kaiyong Huang, Xiaowei Huang, Guodong Lu, Jing Zhou","doi":"10.1016/S1875-5364(26)61225-3","DOIUrl":null,"url":null,"abstract":"<div><div>Chronic cerebral hypoperfusion (CCH) is a major contributor to vascular cognitive impairment (VCI), often resulting in progressive learning and memory deficits. Quercetin (Qu), a natural flavonoid with potent anti-inflammatory and antioxidant properties, demonstrates neuroprotective potential against ischemic injury, yet its mechanism of action remains incompletely understood. In this study, a rat model of CCH was established by bilateral common carotid artery occlusion, followed by Qu administration at doses of 20, 40, and 80 mg·kg<sup>−1</sup>. In parallel, HT22 cells subjected to oxygen-glucose deprivation (OGD) were treated with Qu at 5, 10, or 20 μmol·L<sup>−1</sup>. Behavioral tests, histological staining, ELISA, and Western blot were used to assess cognitive performance, neuronal injury, lysosomal activity, NF-κB pathway activation, and inflammatory cytokine levels. Hippocampal RNA sequencing was also performed. Our results demonstrate that Qu greatly improved cognitive performance and attenuated neuronal damage in both the cerebral cortex and hippocampus. Mechanistically, Qu improved lysosomal function and suppressed NF-κB-mediated neuroinflammatory response, leading to less production of pro-inflammatory cytokines. Notably, co-administration of a lysosomal inhibitor attenuated the neuroprotective effects of Qu, underscoring the functional importance of lysosomal activation. In conclusion, Qu alleviates CCH-induced cognitive decline and neurodegeneration by restoring lysosomal function and inhibiting NF-κB-driven neuroinflammation. These findings support the therapeutic potential of Qu for VCI and provide a rationale for its further development as a neuroprotective agent.</div></div>","PeriodicalId":10002,"journal":{"name":"Chinese Journal of Natural Medicines","volume":"24 11","pages":"Pages 1354-1365"},"PeriodicalIF":7.5000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Natural Medicines","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1875536426612253","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/28 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Chronic cerebral hypoperfusion (CCH) is a major contributor to vascular cognitive impairment (VCI), often resulting in progressive learning and memory deficits. Quercetin (Qu), a natural flavonoid with potent anti-inflammatory and antioxidant properties, demonstrates neuroprotective potential against ischemic injury, yet its mechanism of action remains incompletely understood. In this study, a rat model of CCH was established by bilateral common carotid artery occlusion, followed by Qu administration at doses of 20, 40, and 80 mg·kg−1. In parallel, HT22 cells subjected to oxygen-glucose deprivation (OGD) were treated with Qu at 5, 10, or 20 μmol·L−1. Behavioral tests, histological staining, ELISA, and Western blot were used to assess cognitive performance, neuronal injury, lysosomal activity, NF-κB pathway activation, and inflammatory cytokine levels. Hippocampal RNA sequencing was also performed. Our results demonstrate that Qu greatly improved cognitive performance and attenuated neuronal damage in both the cerebral cortex and hippocampus. Mechanistically, Qu improved lysosomal function and suppressed NF-κB-mediated neuroinflammatory response, leading to less production of pro-inflammatory cytokines. Notably, co-administration of a lysosomal inhibitor attenuated the neuroprotective effects of Qu, underscoring the functional importance of lysosomal activation. In conclusion, Qu alleviates CCH-induced cognitive decline and neurodegeneration by restoring lysosomal function and inhibiting NF-κB-driven neuroinflammation. These findings support the therapeutic potential of Qu for VCI and provide a rationale for its further development as a neuroprotective agent.
期刊介绍:
The Chinese Journal of Natural Medicines (CJNM), founded and sponsored in May 2003 by China Pharmaceutical University and the Chinese Pharmaceutical Association, is devoted to communication among pharmaceutical and medical scientists interested in the advancement of Traditional Chinese Medicines (TCM). CJNM publishes articles relating to a broad spectrum of bioactive natural products, leading compounds and medicines derived from Traditional Chinese Medicines (TCM).
Topics covered by the journal are: Resources of Traditional Chinese Medicines; Interaction and complexity of prescription; Natural Products Chemistry (including structure modification, semi-and total synthesis, bio-transformation); Pharmacology of natural products and prescription (including pharmacokinetics and toxicology); Pharmaceutics and Analytical Methods of natural products.